Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study (Q57109641)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 April 2014

Language	Label	Description	Also known as
English	Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study	scientific article published on 18 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Emilio Bajetta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Laura Catena

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pamela Biondani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Giusi Blanco

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sergio Ricci

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Francesca Pucci

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Monica Valente

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Nadia Bianco

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Chiara Maria Mauri

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Francesca Spada

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

0 references

publication date

18 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

120

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2457-2463

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Current understanding of the molecular biology of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Pancreatic neuroendocrine tumors: the impact of surgical resection on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

mTOR activation in well differentiated pancreatic neuroendocrine tumors: a retrospective study on 34 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28726

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57109641&oldid=2131739541"